Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0028754
Disease: Obesity
Obesity
0.300 Biomarker disease BEFREE The melanin-concentrating hormone receptor 1 (MCHR1) has become an important pharmacological target, since it may be involved in various diseases, such as diabetes, insulin resistance, and obesity. 29948643 2019
CUI: C0028754
Disease: Obesity
Obesity
0.300 Biomarker disease BEFREE In this review, the current approaches to treat obesity such as the development of diacylglycerol Oacyltransferase- 1 inhibitors, growth hormone secretagogue receptor-1a antagonists/inverse agonists, melanocortin-3 receptors agonists and melanin concentrating hormone receptor-1 antagonists, will be discussed. 27320641 2017
CUI: C0028754
Disease: Obesity
Obesity
0.300 Biomarker disease BEFREE A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models. 27986627 2017
CUI: C0028754
Disease: Obesity
Obesity
0.300 Biomarker disease BEFREE We also comment on the utility of small-molecule MCHR1 antagonists for the treatment of obesity and affective disorders compared to existing therapies and provide a critical overview of the potential risks. 19418262 2009
CUI: C0028754
Disease: Obesity
Obesity
0.300 GeneticVariation disease BEFREE In previous studies of associations of variants in the genes UCP2, UCP3, PPARG2, CART, GRL, MC4R, MKKS, SHP, GHRL, and MCHR1 with obesity, we have used a case-control approach with cases defined by a threshold for BMI. 20054173 2008
CUI: C0028754
Disease: Obesity
Obesity
0.300 GeneticVariation disease BEFREE Single nucleotide polymorphisms (SNPs) of the MCHR1 gene have been previously associated with obesity, but the results are inconsistent among different populations. 18198296 2007
CUI: C0028754
Disease: Obesity
Obesity
0.300 Biomarker disease BEFREE This review details the rising need for new treatments for obesity; the rationale and target validation of MCHR1 receptor antagonists as potential treatments for this disease; and the current status of the numerous small molecule MCHR1 antagonists in development by different companies. 17655875 2007
CUI: C0028754
Disease: Obesity
Obesity
0.300 GeneticVariation disease BEFREE However, similar associations were found when both adults and children were analyzed together (P = 0.006, 0.783 [0.658-0.930]), suggesting that severe forms of obesity with early onset may be associated with SNPs in MCHR1. 16186414 2005
CUI: C0028754
Disease: Obesity
Obesity
0.300 GeneticVariation disease BEFREE Mutation analysis of the MCHR1 gene in human obesity. 15941924 2005
CUI: C0028754
Disease: Obesity
Obesity
0.300 Biomarker disease BEFREE Substituted phenyl biaryl urea derivatives were synthesized and evaluated as MCH-R1 antagonists for the treatment of obesity. 16033253 2005
CUI: C0028754
Disease: Obesity
Obesity
0.300 Biomarker disease RGD We used real-time PCR to measure the hypothalamic expression of MCH and its receptor (MCHR1) in two contrasting models of altered nutritional status, namely, obesity induced by 8 weeks' voluntary overeating and food restriction for 10 days. 15363890 2004